43769 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 09
00:49 UTC
|
GRT.UN
Granite Real Estate Investment Trust
|
◎ Target | firm only | Outperform | C$110.00→ C$106.00-3.6% |
|
Aug 09
00:49 UTC
|
GRT.UN
Granite Real Estate Investment Trust
|
◎ Target | firm only | Buy | C$106.00→ C$108.00+1.9% |
|
Aug 09
00:49 UTC
|
GRT.UN
Granite Real Estate Investment Trust
|
◎ Target | firm only | Buy | C$101.00→ C$103.00+2.0% |
|
Aug 09
00:49 UTC
|
GRDN
Guardian Pharmacy Services
|
◎ Target | Michael Wiederhorn ★★★★☆ #345 | Outperform | $43.00→ $49.00+14.0% |
|
Aug 09
00:49 UTC
|
GPCR
Structure Therapeutics
|
◎ Target | Samantha Semenkow ★★☆☆☆ #2597 | Buy | $100.00→ $97.00-3.0% |
|
Aug 09
00:49 UTC
|
GPCR
Structure Therapeutics
|
◎ Target | Jonathan Wolleben ★★★☆☆ #2175 | Market Outperform | $113.00→ $110.00-2.7% |
|
Aug 09
00:49 UTC
|
GMED
Globus Medical
|
◎ Target | Larry Biegelsen ★★★★☆ #604 | Overweight | $103.00→ $99.00-3.9% |
|
Aug 09
00:49 UTC
|
GMAB
Genmab A/S
|
◎ Target | Michael Schmidt ★★★☆☆ #2066 | Buy | $40.00→ $42.00+5.0% |
|
Aug 09
00:49 UTC
|
GLUE
Monte Rosa Therapeutics
|
◎ Target | Michael Schmidt ★★★☆☆ #2066 | Buy | $35.00→ $28.00-20.0% |
|
Aug 09
00:49 UTC
|
GLUE
Monte Rosa Therapeutics
|
◎ Target | Brian Cheng ★★★☆☆ #2146 | Overweight | $31.00→ $27.00-12.9% |
|
Aug 09
00:49 UTC
|
GLUE
Monte Rosa Therapeutics
|
◎ Target | Derek Archila ★★★☆☆ #1876 | Overweight | $29.00→ $27.00-6.9% |
|
Aug 09
00:49 UTC
|
GLEN
Glencore
|
◎ Target | firm only | Buy | GBX 750→ GBX 740-1.3% |
|
Aug 09
00:49 UTC
|
GHRS
GH Research
|
◎ Target | Eddie Hickman ★★★★☆ #601 | Buy | $34.00→ $40.00+17.6% |
|
Aug 09
00:49 UTC
|
GHRS
GH Research
|
◎ Target | Charles Duncan ★★☆☆☆ #2712 | Overweight | $35.00→ $40.00+14.3% |
|
Aug 09
00:49 UTC
|
GENI
Genius Sports
|
◎ Target | Jed Kelly ★★★☆☆ #1485 | Outperform | $10.00→ $12.00+20.0% |
|
Aug 09
00:49 UTC
|
GENI
Genius Sports
|
◎ Target | Bernie McTernan ★★★☆☆ #1756 | Buy | $10.00→ $12.00+20.0% |
|
Aug 09
00:49 UTC
|
GEN
Gen Digital
|
◎ Target | Matthew Hedberg ★★★★☆ #685 | Sec→ r Perform | $27.00→ $30.00+11.1% |
|
Aug 09
00:49 UTC
|
GEN
Gen Digital
|
◎ Target | Saket Kalia ★★★★★ #311 | Equal Weight | $27.00→ $32.00+18.5% |
|
Aug 09
00:49 UTC
|
GEN
Gen Digital
|
◎ Target | Richard Poland ★★★☆☆ #1488 | Equal Weight | $22.00→ $28.00+27.3% |
|
Aug 09
00:49 UTC
|
GDRX
GoodRx
|
◎ Target | Stan Berenshteyn ★★★★☆ #607 | Overweight | $3.50→ $5.00+42.9% |
|
Aug 09
00:49 UTC
|
G
Genpact
|
◎ Target | Bryan Bergin ★★★★☆ #635 | Buy | $42.00→ $43.00+2.4% |
|
Aug 09
00:49 UTC
|
G
Genpact
|
◎ Target | Bryan Keane ★★★★☆ #582 | Neutral | $32.00→ $36.00+12.5% |
|
Aug 09
00:49 UTC
|
G
Genpact
|
◎ Target | Mayank Tandon ★★★★★ #154 | Buy | $50.00→ $45.00-10.0% |
|
Aug 09
00:49 UTC
|
G
Genpact
|
◎ Target | James Friedman ★★★☆☆ #1469 | Neutral | $33.00→ $37.00+12.1% |
|
Aug 09
00:49 UTC
|
G
Genpact
|
◎ Target | Puneet Jain ★★★★★ #323 | Neutral | $40.00→ $45.00+12.5% |
|
Aug 09
00:49 UTC
|
FWRG
First Watch Restaurant Group
|
◎ Target | Gregory Francfort ★★★☆☆ #1752 | Buy | $21.00→ $20.00-4.8% |
|
Aug 09
00:49 UTC
|
FWONK
Liberty Media Corporation - Liberty Formula One Series C
|
◎ Target | Ryan Gravett ★☆☆☆☆ #2950 | Neutral | $104.00→ $110.00+5.8% |
|
Aug 09
00:49 UTC
|
FWONK
Liberty Media Corporation - Liberty Formula One Series C
|
◎ Target | David Karnovsky ★★★★★ #287 | Overweight | $124.00→ $125.00+0.8% |
|
Aug 09
00:49 UTC
|
FWONK
Liberty Media Corporation - Liberty Formula One Series C
|
◎ Target | Steven Cahill not yet tracked | Equal Weight | $97.00→ $105.00+8.2% |
|
Aug 09
00:49 UTC
|
FUN
Six Flags Entertainment
|
◎ Target | Ian Zaffino ★★★☆☆ #1241 | Outperform | $26.00→ $23.00-11.5% |
|
Aug 09
00:49 UTC
|
FUN
Six Flags Entertainment
|
◎ Target | Jordan Bender ★★☆☆☆ #2451 | Market Outperform | $29.00→ $24.00-17.2% |
|
Aug 09
00:49 UTC
|
FUN
Six Flags Entertainment
|
◎ Target | Brandt Montour ★★★☆☆ #1110 | Overweight | $26.00→ $22.00-15.4% |
|
Aug 09
00:49 UTC
|
FTT
Finning International
|
◎ Target | firm only | Outperform | C$118.00→ C$122.00+3.4% |
|
Aug 09
00:49 UTC
|
FTT
Finning International
|
◎ Target | firm only | Outperform | C$115.00→ C$118.00+2.6% |
|
Aug 09
00:49 UTC
|
FTDR
Frontdoor
|
◎ Target | Ian Zaffino ★★★☆☆ #1241 | Outperform | $70.00→ $100.00+42.9% |
|
Aug 09
00:49 UTC
|
FTDR
Frontdoor
|
◎ Target | Mark Hughes ★★★★☆ #663 | Buy | $82.00→ $105.00+28.0% |
|
Aug 09
00:49 UTC
|
FTDR
Frontdoor
|
◎ Target | Michael Rindos ★★☆☆☆ #2762 | Buy | $80.00→ $96.00+20.0% |
|
Aug 09
00:49 UTC
|
FSLR
First Solar
|
◎ Target | Praneeth Satish ★☆☆☆☆ #3106 | Overweight | $300.00→ $313.00+4.3% |
|
Aug 09
00:49 UTC
|
FSK
FS KKR Capital
|
◎ Target | Mark Hughes ★★★★☆ #663 | Hold | $11.00→ $12.00+9.1% |
|
Aug 09
00:49 UTC
|
FROG
JFrog
|
◎ Target | Mike Cikos ★★★★★ #79 | Buy | $80.00→ $115.00+43.8% |
|
Aug 09
00:49 UTC
|
FROG
JFrog
|
◎ Target | Howard Ma ★★★★☆ #363 | Buy | $105.00→ $115.00+9.5% |
|
Aug 09
00:49 UTC
|
FROG
JFrog
|
◎ Target | Jason Celino ★★★★★ #316 | Overweight | $89.00→ $114.00+28.1% |
|
Aug 09
00:49 UTC
|
FROG
JFrog
|
◎ Target | Yi Fu Lee ★★★☆☆ #2088 | Buy | $100.00→ $120.00+20.0% |
|
Aug 09
00:49 UTC
|
FROG
JFrog
|
◎ Target | Brian Essex ★★★★☆ #920 | Overweight | $100.00→ $115.00+15.0% |
|
Aug 09
00:49 UTC
|
FROG
JFrog
|
◎ Target | Rob Owens ★★★★★ #112 | Neutral | $65.00→ $90.00+38.5% |
|
Aug 09
00:49 UTC
|
FROG
JFrog
|
◎ Target | Ittai Kidron ★★★★☆ #477 | Outperform | $105.00→ $115.00+9.5% |
|
Aug 09
00:49 UTC
|
FROG
JFrog
|
◎ Target | Miller Jump ★★★★☆ #652 | Buy | $105.00→ $110.00+4.8% |
|
Aug 09
00:49 UTC
|
FROG
JFrog
|
◎ Target | Nick Altmann ★★★★★ #180 | Buy | $100.00→ $115.00+15.0% |
|
Aug 09
00:49 UTC
|
FROG
JFrog
|
◎ Target | Radi Sultan ★★★★☆ #418 | Buy | $110.00→ $120.00+9.1% |
|
Aug 09
00:49 UTC
|
FROG
JFrog
|
◎ Target | Andrew Sherman ★★★★★ #191 | Buy | $100.00→ $120.00+20.0% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.